Stay updated on Fremanezumab in Preventing Chronic Migraine Clinical Trial
Sign up to get notified when there's something new on the Fremanezumab in Preventing Chronic Migraine Clinical Trial page.

Latest updates to the Fremanezumab in Preventing Chronic Migraine Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe Record History now shows revision v3.3.2 with a Returned date of 2025-11-21 and a QC status of Not Concluded. New sections such as Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and other document sections were added, and the Study Status was updated.SummaryDifference0.5%

- Check28 days agoChange DetectedThe history shows a new 'Results Submitted' status and removes the 'No Results Posted' notice, indicating that trial results have been submitted.SummaryDifference0.3%

- Check42 days agoChange DetectedA new 'Study Status' entry was added to the record history on 2025-10-28, corresponding to version 83 listed on 2025-10-27.SummaryDifference0.2%

- Check64 days agoChange DetectedThe study title changed from “Patients 6 to 17 Years of Age” to “Participants 6 to 17 Years of Age,” the date updated from 2025-01-29 to 2025-10-06, and new metadata sections (Study Identification, Status, Design, Arms and Interventions, Outcome Measures, Eligibility) were added.SummaryDifference2%

- Check71 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference8%

- Check78 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a newer version is now in effect.SummaryDifference0.2%

Stay in the know with updates to Fremanezumab in Preventing Chronic Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fremanezumab in Preventing Chronic Migraine Clinical Trial page.